Suchergebnisse - "Folegatti, Pedro M"

PubPharm (33)

1

Repeat controlled human malaria infection of healthy UK adults with blood-stagePlasmodium falciparum: safety and parasite growth dynamics

enthalten in: bioRxiv.org | 2024

von Salkeld, J. | Themistocleous, Y. | Barrett, J. | +24

2

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults : an open-label, non-randomised, first-in-human phase 1 clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Jenkin, D. | Wright, D. | Folegatti, P. | +16

CommentIn: Lancet Infect Dis. 2023 Aug;23(8):887-889. - PMID 37060918

3

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222) : 1 year of follow-up of two randomized controlled trials

enthalten in: Clinical and experimental immunology | 2023

von Voysey, M. | Flaxman, A. | Aboagye, J. | +34

4

Durability of ChAdOx1 nCov-19 (AZD1222) vaccination in people living with HIV - responses to SARS-CoV-2, variants of concern and circulating coronaviruses

enthalten in: bioRxiv.org | 2023

von Ogbe, A. | Pace, M. | Bittaye, M. | +56

5

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1 : Standardized template with key considerations for a risk/benefit assessment

enthalten in: Vaccine | 2022

von Folegatti, P. | Jenkin, D. | Morris, S. | +8

6

Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR

enthalten in: Journal of clinical microbiology | 2022

von Ratcliff, J. | Al-Beidh, F. | Bibi, S. | +26

7

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

enthalten in: JCI insight | 2022

von Ogbe, A. | Pace, M. | Bittaye, M. | +55

8

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum : Safety and parasite growth dynamics

enthalten in: Frontiers in immunology | 2022

von Salkeld, J. | Themistocleous, Y. | Barrett, J. | +24

9

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial

enthalten in: Lancet (London, England) | 2021

von Ramasamy, M. | Minassian, A. | Ewer, K. | +162

ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142

10

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

enthalten in: Nature medicine | 2021

von Feng, S. | Phillips, D. | White, T. | +96